Mellor R, Kearnes M, Lancaster K, McLauchlan L, Ritter A. Established tables and emergent huddles: exploring the processes of participation associated with the policy changes to opioid pharmacotherapy treatment in Australia in the context of COVID-19. Contemp Drug Probl. 2022 Sep 8;49(4):385-404. doi: 10.1177/00914509221123001
Zanini MJ, Dominguez C, Fernandez-Oliva T, Sanchez O, Toda MT, Foraster M, Dadvand P, Llurba E. Urban-related environmental exposures during pregnancy and placental development and preeclampsia: a review. Curr Hypertens Rep. 2020 Sep 3;22(10):81. doi: 10.1007/s11906-020-01088-4
Candrilli SD, Manjunath R, Davis KL, Gidal BE. The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy. Epilepsy Res. 2010 Oct 1;91(2-3):260-6.